Showing results (31-40 of 76) with videos related to
Sort By:
Pageof 8
Cancer|February 4, 2010
Toxicity and efficacy of combined radioimmunotherapy and bevacizumab in a mouse model of medullary thyroid carcinomaPierre-Yves Salaun, Caroline Bodet-Milin, Eric Frampas, et al.European Journal of Nuclear Medicine and Molecular Imaging|May 3, 2005
Improved pretargeted delivery of radiolabelled hapten to human tumour xenograft in mice by avidin chase of circulating bispecific antibodyEric Mirallié, Catherine Saï-Maurel, Alain Faivre-Chauvet, et al.Organic & Biomolecular Chemistry|October 1, 2015
New synthesis of phenyl-isothiocyanate C-functionalised cyclams. Bioconjugation and (64)Cu phenotypic PET imaging studies of multiple myeloma with the te2a derivativeZakaria Halime, Mathieu Frindel, Nathalie Camus, et al.Organic & Biomolecular Chemistry|March 24, 2016
Correction: New synthesis of phenyl-isothiocyanate C-functionalised cyclams. Bioconjugation and (64)Cu phenotypic PET imaging studies of multiple myeloma with the te2a derivativeZakaria Halime, Mathieu Frindel, Nathalie Camus, et al.Molecular Cancer Therapeutics|December 7, 2002
Enhanced antitumor activity of combined pretargeted radioimmunotherapy and paclitaxel in medullary thyroid cancer xenograftFrançoise Kraeber-Bodéré, Catherine Saï-Maurel, Loïc Campion, et al.Neoplasia (New York, N.Y.)|May 28, 2014
Antitumor immunity induced after α irradiationJean-Baptiste Gorin, Jérémie Ménager, Sébastien Gouard, et al.Seminars in Nuclear Medicine|February 22, 2016
Radioimmunotherapy for Treatment of Acute LeukemiaCaroline Bodet-Milin, Françoise Kraeber-Bodéré, Thomas Eugène, et al.Pharmaceutics|January 16, 2021
Impact of DOTA Conjugation on Pharmacokinetics and Immunoreactivity of [177Lu]Lu-1C1m-Fc, an Anti TEM-1 Fusion Protein Antibody in a TEM-1 Positive Tumor Mouse ModelJudith Anna Delage, Alain Faivre-Chauvet, Jacques Barbet, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
Binding activities and antitumor properties of a new mouse/human chimeric antibody specific for GD2 ganglioside antigenNidia Alvarez-Rueda, Stéphanie Leprieur, Béatrice Clémenceau, et al.Frontiers in Medicine|March 3, 2020
Cell Tracking in Cancer ImmunotherapyJustine Perrin, Marisa Capitao, Marie Mougin-Degraef, et al.Pageof 8